https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-01 / Clin. Exp. Pharmacol. Physiol. 2006 May-Jun;33(5-6):569-74
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-01 / Clin. Exp. Pharmacol. Physiol. 2006 May-Jun;33(5-6):569-742006-05-01 00:00:002006-05-01 00:00:00Targeting tumours by adoptive transfer of immune cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-01 / Int. J. Cancer 2006 May;118(9):2220-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-01 / Int. J. Cancer 2006 May;118(9):2220-312006-05-01 00:00:002006-05-01 00:00:00Short-term dietary administration of celecoxib enhances the efficacy of tumor lysate-pulsed dendritic cell vaccines in treating murine breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-01 / Clin. Exp. Immunol. 2006 Apr;144(1):41-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-01 / Clin. Exp. Immunol. 2006 Apr;144(1):41-72006-04-01 00:00:002006-04-01 00:00:00Cancer immunotherapy using dendritic/tumour-fusion vaccine induces elevation of serum anti-nuclear antibody with better clinical responses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-05-01 / J. Clin. Oncol. 2005 May;23(13):3079-85
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-05-01 / J. Clin. Oncol. 2005 May;23(13):3079-852005-05-01 00:00:002005-05-01 00:00:00Randomized trial of hyperthermia and radiation for superficial tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-02-01 / Scand. J. Immunol. 2005 Feb;61(2):147-56
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-02-01 / Scand. J. Immunol. 2005 Feb;61(2):147-562005-02-01 00:00:002019-02-15 08:50:24Phenotypic and functional characterization of clinical grade dendritic cells generated from patients with advanced breast cancer for therapeutic vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-01-01 / Nutr Cancer 2005;53(2):177-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-01-01 / Nutr Cancer 2005;53(2):177-932005-01-01 00:00:002019-02-15 08:50:23Chemo-immunotherapy of breast cancer using vesiculated alpha-tocopheryl succinate in combination with dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-01-01 / Curr. Pharm. Des. 2005;11(27):3475-83
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-01-01 / Curr. Pharm. Des. 2005;11(27):3475-832005-01-01 00:00:002019-02-15 08:50:23Immunotherapy and cancer vaccines in the management of breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-11-01 / Cancer Res. 2004 Nov;64(21):8022-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-11-01 / Cancer Res. 2004 Nov;64(21):8022-82004-11-01 00:00:002019-02-15 08:50:25Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-07-15 / Clin. Cancer Res. 2004 Jul;10(14):4699-708
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-07-15 / Clin. Cancer Res. 2004 Jul;10(14):4699-7082004-07-15 00:00:002004-07-15 00:00:00Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-06-08 / Cancer Immunol. Immunother. 2004 Sep;53(9):777-85
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-06-08 / Cancer Immunol. Immunother. 2004 Sep;53(9):777-852004-06-08 00:00:002019-02-15 08:50:26Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer
